Hydro-Ethanolic Extract of Portulaca Oleracea Ameliorates Total and Differential WBC, Lung Pathology and Oxidative Biomarkers in Asthmatic Rats

Document Type : Research article


1 Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

2 Department of Physiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

3 Natural Products and Medicinal Plants Research Centre, North Khorasan University of Medical Sciences, Bojnurd, Iran.

4 Department of Pathology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

5 Clinical Research Unit, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.


Objective: The effects of Portulaca oleracea (P. oleracea; PO) on total and differential WBC count, and oxidant/antioxidant biomarkers in bronchoalveolar lavage fluid (BALF) as well as on lung pathology in asthmatic rats were examined.
Methods and Methods: Rats were randomly divided into; control group (C), asthma group, asthma groups treated with either P. oleracea (rats that received PO 1, 2 and 4 mg/ml) or dexamethasone 1.25 μg/ml (D), (n=8 in each group). Total and differential white blood cells (WBC) count, nitrite (NO2), nitrate (NO3), malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT) and thiol levels in rats BALF were evaluated and lung pathological features were studied.
Results: Total WBC count, eosinophil, neutrophil and monocyte percentages, levels of NO2, NO3, MDA in the BALF and most pathological scores in the lung were increased but lymphocyte percentage, SOD, CAT and thiol levels were decreased in the BALF of asthmatic animals (p Conclusion: Our results demonstrated the ameliorative effects of P. oleracea on total and differential WBC count and oxidant-antioxidant biomarkers levels in BALF as well as lung pathological features in asthmatic rats, which propose the usage of this extract as a preventive anti-inflammatory treatment against asthma.


Rashed A, Afifi F and Disi A. Simple evaluation of the
wound healing activity of a crude extract of Portulaca
oleracea L.(growing in Jordan) in Mus musculus JVI1. J. Ethnopharmacol. (2003) 88: 131-6.
Uddin MK, Juraimi AS, Hossain MS, Nahar MAU,
Portulaca oleracea ameliorates lung inflammation and oxidative stress in asthmatic rats
Ali ME and Rahman M. Purslane weed (Portulaca
oleracea): a prospective plant source of nutrition,
omega-3 fatty acid, and antioxidant attributes. Sci.
World J. (2014) 2014: 1-6.
Malek F, Boskabady M, Borushaki M and Tohidi
M. Bronchodilatory effect of Portulaca oleracea in
airways of asthmatic patients. J. Ethnopharmacol.
(2004) 93: 57-62.
Boskabady MH, Boroushaki M and Aslani MR.
Relaxant effect of Portulaca oleraceae on guinea
pig tracheal chains and its possible mechanism (s) of
action. Med. Hypotheses. Res. (2004) 1: 139-47.
Dkhil MA, Moniem AEA, Al-Quraishy S and Saleh
RA. Antioxidant effect of purslane (Portulaca
oleracea) and its mechanism of action. J. Med. Plants
Res. (2011) 5: 1589-93.
Boroushaki MT, Boskabady MH and Malek F.
Antitussive effect of Portulaca oleracea L. in guinea
pigs. Iran. J. Pharm. Res. (2010) 1: 187-90.
Boskabady MH, Kaveh M, Shakeri F, Mohammadian
Roshan N and Rezaee R. Alpha-linolenic acid
ameliorates bronchial asthma features in ovalbuminsensitized rats. J. Pharm. Pharmacol. (2019) 71: 1089-
Kaveh M, Eidi A, Neamati A and Boskabady MH.
Modulation of lung inflammation and immune markers
in asthmatic rats treated by Portulaca oleracea.
Avicenna J. Phytomed. (2017) 1: 1-11.
Kaveh M, Eidi A, Nemati A and Boskabady MH. The
Extract of Portulaca oleracea and its Constituent,
Alpha Linolenic Acid Affects Serum Oxidant Levels
and Inflammatory Cells in Sensitized Rats. Iran. J.
Allergy Asthma Immunol. (2017) 16: 256-70.
Lee AS, Kim JS, Lee YJ, Kang DG and Lee HS.
Anti-TNF-α activity of Portulaca oleracea in vascular
endothelial cells. Int. J. Mol. Sci. (2012) 13: 5628-44.
Ishmael FT. The inflammatory response in the
pathogenesis of asthma. J. Am. Osteopath. Assoc.
(2011) 111: 7-11.
James AL, Bai TR, Mauad T, Abramson MJ, Dolhnikoff
M, McKay KO, Maxwell PS, Elliot JG and Green FH.
Airway smooth muscle thickness in asthma is related
to severity but not duration of asthma. Eur. Respir. J.
(2009) 34: 1040-5.
Bradley BL, Azzawi M, Jacobson M, Assoufi B,
Collins JV, Irani AM, Schwartz LB, Durham SR,
Jeffery PK and Kay AB. Eosinophils, T-lymphocytes,
mast cells, neutrophils, and macrophages in bronchial
biopsy specimens from atopic subjects with asthma:
comparison with biopsy specimens from atopic
subjects without asthma and normal control subjects
and relationship to bronchial hyperresponsiveness. J.
Allergy Clin. Immunol. (1991) 88: 661-74.
Lacoste JY, Bousquet J, Chanez P, Van Vyve T, SimonyLafontaine J, Lequeu N, Vic P, Enander I, Godard
P and Michel FB. Eosinophilic and neutrophilic
inflammation in asthma, chronic bronchitis, and
chronic obstructive pulmonary disease. J. Allergy Clin.
Immunol. (1993) 92: 537-48.
Luksza A and Jones D. Comparison of whole-blood
eosinophil counts in extrinsic asthmatics with acute
and chronic asthma. Br. Med. J. (Clin Res Ed). (1982)
285: 1229-31.
Shakeri F, Soukhtanloo M and Boskabady MH. The
effect of hydro-ethanolic extract of Curcuma longa
rhizome and curcumin on total and differential WBC
and serum oxidant, antioxidant biomarkers in rat
model of asthma. Iran. J. Basic Med. Sci. (2017) 20:
Barnes PJ. Pathogenesis of asthma: a review. J. R. Soc.
Med. (1983) 76: 580-6.
Barrios RJ, Kheradmand F, Batts LK and Corry DB.
Asthma: pathology and pathophysiology. Arch. Pathol.
Lab Med. (2006) 130: 447-51.
Shifren A, Witt C, Christie C and Castro M.
Mechanisms of remodeling in asthmatic airways. J.
Allergy (2012) 2012: 1-12.
Shakeri F and Boskabady MH. Anti‐inflammatory,
antioxidant, and immunomodulatory effects of
curcumin in ovalbumin‐sensitized rat. Biofactors
(2017) 42: 567-76.
Shakeri F, Mohamadian Roshan N, Kaveh M, Eftekhar
N and Boskabady MH. Curcumin affects tracheal
responsiveness and lung pathology in asthmatic rats.
Pharmacol. Rep. (2018) 70: 981-7.
Ibn Sina H. al-Qanun fi al-Tibb. IS aD, editor. (2005)
2: 417-8.
Razi M. Al-Hawi fi›l-tibb (Comprehensive book of
medicine). Hyderabad: Osmania Oriental Publications
Bureau. (1968) 20: 548-53.
Banerjee G and Mukherjee A. Antibacterial activity
of a common weed, Portviaca oleracea L. Geobios.
(2003) 30: 143-4.
Arruda SF, Siqueira EM and Souza EM. Malanga
(Xanthosoma sagittifolium) and purslane (Portulaca
oleracea) leaves reduce oxidative stress in vitamin
A-deficient rats. Ann. Nutr Metab. (2004) 48: 288-95.
Xiao F, Lu F and Xu L. Effect of different parts of
Portulace oleracea on the levels of TNF-alpha and IL-6
in the supernatant of cultured adipose cell. Zhongguo
Zhong Yao Za Zhi. (2005) 30: 1763-6.
Meng Y, Ying Z, Xiang Z, Hao D, Zhang W, Zheng
Y, Gao Y, Ying X. The anti‐inflammation and
pharmacokinetics of a novel alkaloid from Portulaca
oleracea L. J Pharm. Pharmacol. (2016) 68: 397-405.
Khoury P, Grayson PC and Klion AD. Eosinophils in
vasculitis: characteristics and roles in pathogenesis.
Nat. Rev. Rheumatol. (2014) 10: 474-83.
Trivedi S and Lloyd C. Eosinophils in the pathogenesis
of allergic airways disease. Cell Mol. Life Sci. (2007)
64 1269-89.
Sackesen C, Ercan H, Dizdar E, Soyer O, Gumus P,
Tosun BN, Büyüktuncer Z, Karabulut E, Besler T
and Kalayci O. A comprehensive evaluation of the
enzymatic and nonenzymatic antioxidant systems in
childhood asthma. J. Allergy Clin. Immunol. (2008)
122: 78-85.
Rahman I, Morrison D, Donaldson K and MacNee 
 Boskabady MH et al. / IJPR (2019), 18 (4): 1947-1958
sensitized rats. Int. J. Vitam. Nutr. Res. (2019) 1:1-10.
Yue T, Xiaosa W, Ruirui Q, Wencai S, Hailiang X and
Min L. The Effects of Portulaca oleracea on HypoxiaInduced Pulmonary Edema in Mice. High Alt. Med.
Biol. (2015) 16: 43-51.